ASCO 2023: Integra Connect to Showcase how its Technology an

/PRNewswire/ -- Integra Connect, LLC., the leading provider of value-based, precision medicine solutions and services for specialty care, today announced that...

Related Keywords

United States , American , Parpi Monotherapy , Jeffreya Scott , Alyssa Howerton , Garret Hampton , Linkedin , American Society Of Clinical Oncology , Promising Tool For Community Practices , Integra Connect , Equality Initiative , Health Services Research , Population Health Solutions At Integra , Thermo Fisher , Clinical Oncology , Annual Meeting , Thermo Fisher Scientific , Testing Advances Precision Oncology , Decisions Impact End Of Life Patient Outcomes , Machine Learning Technologies , Promising Tool , Community Practices , Real World Data Delivers , Evidence Based Decision Making , Chief Medical Officer , Population Health Solutions , Fisher Scientific , Integra Research Highlights Value , Rapid Genomic , World Testing , Treatment Patterns Among Patients , Small Cell Lung Cancer , Retrospective Observational Study , Session Title , Lung Cancer , Small Cell Metastatic , Connect Pinpoints Ways , Improve Patient Outcomes , Oncology Care Model , Quality Improvement , Gynecologic Cancer , Integra Connect Precision , Oncology Care , Organizations Utilize Integra Connect , Value Based Care Focused Real World Data , Advance Evidence Based Cancer , World Outcomes , First Line Maintenance , Advanced Ovarian , Polymerase Inhibitors , Resistant Prostate Cancer , Homologous Recombination Repair , Ovarian Cancer Treated , Line Maintenance , Differences Related , Treated Win Routine Care Settings ,